Expression and possible implication of growth hormone-releasing hormone receptor splice variant 1 in endometriosis

Fertility and Sterility

Volumn 92, Issue 1, 2009, Pages 47-53

  Fu, Li ^a   Osuga, Yutaka ^a   Yano, Tetsu ^a   Takemura, Yuri ^a   Morimoto, Chieko ^a   Hirota, Yasushi ^a   Schally, Andrew V ^b   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Endometriosis; GHRH; proliferation; SV1

Indexed keywords

BROXURIDINE; CYCLIC AMP; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR SPLICE VARIANT 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ECTOPIC TISSUE; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL;

ADULT; ALTERNATIVE SPLICING; ANTIGENS, CD45; BONE MARROW CELLS; DNA PRIMERS; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; GROWTH HORMONE-RELEASING HORMONE; HUMANS; LAPAROSCOPY; MENSTRUAL CYCLE; OVARY; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

EID: 67649271511     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.04.048     Document Type: Article

References (34)

1. Matsuzaki S., Canis M., Pouly J.L., Botchorishvili R., Dechelotte P.J., and Mage G. Differential expression of genes in eutopic and ectopic endometrium from patients with ovarian endometriosis. Fertil Steril 86 (2006) 548-553
2. Wu Y., Kajdacsy-Balla A., Strawn E., Basir Z., Halverson G., Jailwala P., et al. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 147 (2006) 232-246
3. Mayo K.E., Miller T., DeAlmeida V., Godfrey P., Zheng J., and Cunha S.R. Regulation of the pituitary somatotroph cell by GHRH and its receptor. Recent Prog Horm Res 55 (2000) 237-266
4. Kiaris H., Schally A.V., and Kalofoutis A. Extrapituitary effects of the growth hormone-releasing hormone. Vitam Horm 70 (2005) 1-24
5. Kineman R.D. Antitumorigenic actions of growth hormone-releasing hormone antagonists. Proc Natl Acad Sci USA 97 (2000) 532-534
6. Schally A.V., and Varga J.L. Antagonists of growth hormone-releasing hormone in oncology. Comb Chem High Throughput Screen 9 (2006) 163-170
7. Schally A.V., Comaru-Schally A.M., Nagy A., Kovacs M., Szepeshazi K., Plonowski A., et al. Hypothalamic hormones and cancer. Front Neuroendocrinol 22 (2001) 248-291
8. Busto R., Schally A.V., Varga J.L., Garcia-Fernandez M.O., Groot K., Armatis P., et al. The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas. Proc Natl Acad Sci USA 99 (2002) 11866-11871
9. Busto R., Schally A.V., Braczkowski R., Plonowski A., Krupa M., Groot K., et al. Expression of mRNA for growth hormone-releasing hormone and splice variants of GHRH receptors in human malignant bone tumors. Regul Pept 108 (2002) 47-53
10. Garcia-Fernandez M.O., Schally A.V., Varga J.L., Groot K., and Busto R. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation. Breast Cancer Res Treat 77 (2003) 15-26
11. Halmos G., Schally A.V., Varga J.L., Plonowski A., Rekasi Z., and Czompoly T. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone. Proc Natl Acad Sci USA 97 (2000) 10555-10560
12. Halmos G., Schally A.V., Czompoly T., Krupa M., Varga J.L., and Rekasi Z. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer. J Clin Endocrinol Metab 87 (2002) 4707-4714
13. Kiaris H., Schally A.V., Busto R., Halmos G., Artavanis-Tsakonas S., and Varga J.L. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. Proc Natl Acad Sci USA 99 (2002) 196-200
14. Rekasi Z., Czompoly T., Schally A.V., and Halmos G. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc Natl Acad Sci USA 97 (2000) 10561-10566
15. Rekasi Z., Varga J.L., Schally A.V., Plonowski A., Halmos G., Csernus B., et al. Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways. Peptides 22 (2001) 879-886
16. Morimoto C., Osuga Y., Yano T., Takemura Y., Harada M., Hirata T., et al. GnRH II as a possible cytostatic regulator in the development of endometriosis. Hum Reprod 20 (2005) 3212-3218
17. Kempuraj D., Papadopoulou N., Stanford E.J., Christodoulou S., Madhappan B., Sant G.R., et al. Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin. Am J Reprod Immunol 52 (2004) 267-275
18. Christodoulou C., Schally A.V., Chatzistamou I., Kondi-Pafiti A., Lamnissou K., Kouloheri S., et al. Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues. Regul Pept 136 (2006) 105-108
19. Khorram O., Garthwaite M., Grosen E., and Golos T. Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Fertil Steril 75 (2001) 174-179
20. Yoshino O., Osuga Y., Koga K., Hirota Y., Tsutsumi O., Yano T., et al. Concentrations of interferon-gamma-induced protein-10 (IP-10), an antiangiogenic substance, are decreased in peritoneal fluid of women with advanced endometriosis. Am J Reprod Immunol 50 (2003) 60-65
21. Hirota Y., Osuga Y., Hirata T., Harada M., Morimoto C., Yoshino O., et al. Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells. Hum Reprod 20 (2005) 3547-3553
22. Hirota Y., Osuga Y., Hirata T., Yoshino O., Koga K., Harada M., et al. Possible involvement of thrombin/protease-activated receptor 1 system in the pathogenesis of endometriosis. J Clin Endocrinol Metab 90 (2005) 3673-3679
23. Kiaris H., Schally A.V., Varga J.L., Groot K., and Armatis P. Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma. Proc Natl Acad Sci USA 96 (1999) 14894-14898
24. Engel J.B., Keller G., Schally A.V., Toller G.L., Groot K., Havt A., et al. Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone. J Clin Endocrinol Metab 90 (2005) 3614-3621
25. Tang X., Yano T., Osuga Y., Matsumi H., Yano N., Xu J., et al. Cellular mechanisms of growth inhibition of human epithelial ovarian cancer cell line by LH-releasing hormone antagonist Cetrorelix. J Clin Endocrinol Metab 87 (2002) 3721-3727
26. Kahan Z., Varga J.L., Schally A.V., Rekasi Z., Armatis P., Chatzistamou L., et al. Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice. Breast Cancer Res Treat 60 (2000) 71-79
27. Rekasi Z., Varga J.L., Schally A.V., Halmos G., Armatis P., Groot K., et al. Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers. Endocrinology 141 (2000) 2120-2128
28. Freddi S., Arnaldi G., Fazioli F., Scarpelli M., Appolloni G., Mancini T., et al. Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours. Clin Endocrinol (Oxf) 62 (2005) 533-538
29. Havt A., Schally A.V., Halmos G., Varga J.L., Toller G.L., Horvath J.E., et al. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci USA 102 (2005) 17424-17429
30. Schulz S., Rocken C., and Schulz S. Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody. Eur J Cancer 42 (2006) 2390-2396
31. Chatzistamou I., Schally A.V., Varga J.L., Groot K., Armatis P., Busto R., et al. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice. J Clin Endocrinol Metab 86 (2001) 2144-2152
32. Gallego R., Pintos E., Garcia-Caballero T., Raghay K., Boulanger L., Beiras A., et al. Cellular distribution of growth hormone-releasing hormone receptor in human reproductive system and breast and prostate cancers. Histol Histopathol 20 (2005) 697-706
33. Rekasi Z., Varga J.L., Schally A.V., Halmos G., Groot K., and Czompoly T. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro. Proc Natl Acad Sci USA 97 (2000) 1218-1223
34. Kahan Z., Arencibia J.M., Csernus V.J., Groot K., Kineman R.D., Robinson W.R., et al. Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J Clin Endocrinol Metab 84 (1999) 582-589